CompletedNCT02620254
Mast Cell Connect: A Registry for Patients With Mastocytosis
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Blueprint Medicines Corporation
- Principal Investigator
- Anthony L Boral, MD, PhD, FNP-BCBlueprint Medicines Corporation
- Enrollment
- 743 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2021
Study locations (1)
- Registry participation is worldwide and not limited to this facility, Cambridge, Massachusetts, United States
Collaborators
PatientCrossroads
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02620254 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.